Literature DB >> 10483939

Cause of death in clinical research: time for a reassessment?

M S Lauer1, E H Blackstone, J B Young, E J Topol.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10483939     DOI： 10.1016/s0735-1097(99)00250-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  131 in total

Review 1.  Evaluation of large scale clinical trials and their application to usual practice.

Authors:  A M Tonkin
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

2.  Improving ascertainment of sudden cardiac death in patients with end stage renal disease.

Authors:  Patrick H Pun; Charles A Herzog; John P Middleton
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

Review 3.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

4.  Predictors and incremental prognostic value of left ventricular mechanical dyssynchrony response during stress-gated positron emission tomography in patients with ischemic cardiomyopathy.

Authors:  Wael AlJaroudi; M Chadi Alraies; Venu Menon; Richard C Brunken; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2012-06-13       Impact factor: 5.952

5.  Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease.

Authors:  Jennifer L Lund; Linda C Harlan; K Robin Yabroff; Joan L Warren
Journal:  Cancer Invest       Date:  2010-08       Impact factor: 2.176

6.  Synergistic effect of coronary artery disease risk factors on long-term survival in patients with normal exercise SPECT studies.

Authors:  Azhar Supariwala; Seth Uretsky; Padmakshi Singh; Salim Memon; Surinder S Khokhar; Omar Wever-Pinzon; Prashanth Atluri; Joseph Hersh; Hari K Koppuravuri; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2010-12-24       Impact factor: 5.952

7.  Prognostic value of myocardium perfusion imaging with a new reconstruction algorithm.

Authors:  Ronaldo Lima; Lima Ronaldo; Andrea De Lorenzo; De Lorenzo Andrea; Gabriel Camargo; Camargo Gabriel; Gabriel Oliveira; Oliveira Gabriel; Thiago Reis; Reis Thiago; Thais Peclat; Peclat Thais; Tamara Rothstein; Rothstein Tamara; Ilan Gottlieb; Gottlieb Ilan
Journal:  J Nucl Cardiol       Date:  2013-11-27       Impact factor: 5.952

8.  Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Authors:  H S Gurm; D L Bhatt; A M Lincoff; J E Tcheng; D J Kereiakes; N S Kleiman; G Jia; E J Topol
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

9.  Prognostic value of left ventricular mechanical dyssynchrony by phase analysis in patients with non-ischemic cardiomyopathy with ejection fraction 35-50% and QRS < 150 ms.

Authors:  Adam S Goldberg; M Chadi Alraies; Manuel D Cerqueira; Wael A Jaber; Wael A Aljaroudi
Journal:  J Nucl Cardiol       Date:  2013-10-04       Impact factor: 5.952

10.  Prognosis in patients with suspected or known ischemic heart disease and normal myocardial perfusion: long-term outcome and temporal risk variations.

Authors:  Jane A Simonsen; Oke Gerke; Charlotte K Rask; Mohammad Tamadoni; Anders Thomassen; Søren Hess; Allan Johansen; Hans Mickley; Lisette O Jensen; Jesper Hallas; Werner Vach; Poul F Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2013-03-01       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.